샘플 요청 목록

 카트 문의
시장보고서
상품코드
1671138

세계의 유방 병변 국소화 시장 규모, 점유율, 동향, 업계 분석 : 종류별, 지역별 - 시장 예측(2025-2034년)

Breast Lesion Localization Methods Market Size, Share, Trends, Industry Analysis Report: By Type and Region - Market Forecast, 2025-2034
발행일: | 리서치사: Polaris Market Research | 페이지 정보: 영문 119 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면, 세계 유방 병변 국소화 시장 규모는 2034년까지 47억 2,306만 달러에 달할 것으로 예상됩니다. 이 보고서는 현재 시장 역학에 대한 자세한 인사이트와 향후 시장 성장에 대한 분석을 제공합니다.

유방 병변 국소화 시장은 유방암 유병률 증가, 영상 기술의 발전, 최소침습적 시술에 대한 수요 증가 등 여러 요인에 의해 주도되고 있습니다. 조기 발견에 대한 인식의 증가와 수술 성적의 향상도 유방 병변 국소화 시장의 성장에 기여하고 있습니다. 주요 동향으로는 방사성 시드 및 자기 추적자를 이용한 국소화 등 보다 정확하고 환자 친화적인 기술로의 전환이 있으며, 이는 불편함을 최소화하고 회복 시간을 단축하는 데 도움이 됩니다.

유방 병변 국소화의 시장 기회는 신흥 지역, 특히 의료 인프라가 개선되고 유방암 탐지 기술에 대한 수요가 증가하고 있는 아시아태평양 및 라틴아메리카에 존재합니다. 개인화된 치료 접근법과 혁신적인 기술이 계속 발전함에 따라 정확성과 환자 치료 강화에 중점을 두면서 이 시장은 꾸준히 성장할 것으로 예상됩니다.

유방 병변 국소화 시장 : 분석 개요

유형별로 보면 와이어 유도 국소화는 이미 확립된 신뢰성과 편의성으로 인해 널리 사용되고 있기 때문에 시장의 지배적인 부문으로 남아 있습니다. 방사성동위원소 국소화는 정확성과 환자 편의성으로 인해 최소침습적 치료로 전환하면서 가장 빠른 성장세를 보이고 있습니다.

북미는 첨단 국소화 기술 채택이 활발하고 의료 시스템이 잘 구축되어 있어 세계 시장을 주도하고 있습니다. 반면, 아시아태평양의 유방 병변 국소화 시장은 의료 인프라 개선, 유방암에 대한 인식 제고, 첨단 진단법 채택 증가에 힘입어 빠르게 성장하고 있습니다.

이 시장의 주요 기업으로는 홀로직, C.R. Bird(BD가 인수한 C.R. Bird), MiMedx Group, 쿡 메디컬 등이 있으며, 와이어 가이드법, 방사성동위원소법 등 다양한 국소화 기술을 제공하고 있습니다. 그 외 자기시드 국소화를 전문으로 하는 Endomag, 유방암 수술용 국소화 제품 공급업체인 IZI Medical Products도 큰 기여를 하고 있습니다.

목차

제1장 소개

제2장 주요 요약

제3장 분석 방법

제4장 유방 병변 국소화 시장 인사이트

  • 시장 현황
  • 유방 병변 국소화 시장 역학
    • 성장 촉진요인과 기회
      • 영상 기술의 진보
      • 최소침습 수술로의 이동
      • 개별화 및 표적 치료 접근법 채용 증가
    • 성장 억제요인과 과제
      • 높은 시술 비용
  • PESTLE 분석
  • 유방 병변 국소화 시장 동향
  • 밸류체인 분석
  • COVID-19의 영향 분석

제5장 세계의 유방 병변 국소화 시장 : 종류별

  • 주요 분석 결과
  • 소개
  • 와이어 유도 국소화
  • 방사성동위원소 국소화
  • 자기 트레이서
  • 기타

제6장 세계의 유방 병변 국소화 시장 : 지역별

  • 주요 분석 결과
  • 소개
    • 유방 병변 국소화 시장 평가 : 지역별(2020-2034년)
  • 북미
    • 북미 : 종류별(2020-2034년)
    • 미국
    • 캐나다
  • 유럽
    • 유럽 : 종류별(2020-2034년)
    • 영국
    • 프랑스
    • 독일
    • 이탈리아
    • 스페인
    • 네덜란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 아시아태평양 : 종류별(2020-2034년)
    • 중국
    • 인도
    • 말레이시아
    • 일본
    • 인도네시아
    • 한국
    • 호주
    • 기타 아시아태평양
  • 중동 및 아프리카
    • 중동 및 아프리카 : 종류별(2020-2034년)
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 남아프리카공화국
    • 기타 중동 및 아프리카
  • 라틴아메리카
    • 라틴아메리카 : 종류별(2020-2034년)
    • 멕시코
    • 브라질
    • 아르헨티나
    • 기타 라틴아메리카

제7장 경쟁 구도

  • 사업 확대·기업 인수 분석
    • 사업 확대
    • 기업 인수
  • 제휴/협업/합의/공개

제8장 기업 개요

  • Hologic Inc.
  • C.R. Bard(acquired by BD)
  • MiMedx Group Inc.
  • Cook Medical
  • Endomag
  • IZI Medical Products
  • Thermo Fisher Scientific
  • GE Healthcare
  • Magee-Womens Hospital
  • Siemens Healthineers
  • Medtronic
  • Philips Healthcare
  • Fujifilm Corporation
  • Johnson & Johnson
  • Canon Medical Systems
ksm 25.03.31

The global breast lesion localization methods market size is expected to reach USD 4,723.06 million by 2034, according to a new study by Polaris Market Research. The report "Breast Lesion Localization Methods Market Size, Share, Trends, Industry Analysis Report: By Type (Wire Guided Localization, Radioisotope Localization, Magnetic Tracer, and Others) and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The breast lesion localization methods market is driven by several factors, including the increasing prevalence of breast cancer, advancements in imaging technologies, and growing demand for minimally invasive procedures. The rising awareness of early detection and improved surgical outcomes also contribute to the breast lesion localization methods market growth. Key trends include the shift towards more precise, patient-friendly techniques such as radioactive seed and magnetic tracer localization, which minimize discomfort and reduce recovery times.

Breast lesion localization methods market opportunities exist in emerging regions, particularly in Asia Pacific and Latin America, where healthcare infrastructure is improving, and the demand for breast cancer detection technologies is rising. As personalized treatment approaches and innovative technologies continue to evolve, the market is expected to experience steady growth, with a focus on enhancing both accuracy and patient care.

Breast Lesion Localization Methods Market Report Highlights

Based on type, wire guided localization remains the dominant segment in the market, as it is widely used due to its established reliability and simplicity. The radioisotope localization segment is experiencing the fastest growth, driven by its precision and patient comfort, with an increasing shift towards minimally invasive procedures.

North America dominates the global market, with strong adoption of advanced localization technologies and well-established healthcare systems. Meanwhile, the Asia Pacific breast lesion localization methods market is witnessing rapid growth, supported by improving healthcare infrastructure, rising breast cancer awareness, and increasing adoption of advanced diagnostic methods.

A few of the key players in the market include Hologic Inc., C.R. Bard (acquired by BD), MiMedx Group Inc., and Cook Medical, which offer a range of localization technologies, such as wire-guided and radioisotope methods. Other significant contributors are Endomag, which specializes in magnetic seed localization, and IZI Medical Products, a supplier of localization products for breast cancer surgery.

Polaris Market Research has segmented the breast lesion localization methods market report on the basis of type and region:

By Type Outlook (Revenue-USD Million, 2020-2034)

  • Wire Guided Localization
  • Radioisotope Localization
  • Magnetic Tracer
  • Others

By Regional Outlook (Revenue-USD Million, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Breast Lesion Localization Methods Market Insights

  • 4.1. Breast Lesion Localization Methods Market - Market Snapshot
  • 4.2. Breast Lesion Localization Methods Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Advancements in Imaging Technologies
      • 4.2.1.2. Shift Toward Minimally Invasive Procedures
      • 4.2.1.3. Rising Adoption of Personalized and Targeted Treatment Approaches
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost of the Methods
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Breast Lesion Localization Methods Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Breast Lesion Localization Methods Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • 5.3. Wire Guided Localization
    • 5.3.1. Global Breast Lesion Localization Methods Market, by Wire Guided Localization, by Region, 2020-2034 (USD Million)
  • 5.4. Radioisotope Localization
    • 5.4.1. Global Breast Lesion Localization Methods Market, by Radioisotope Localization, by Region, 2020-2034 (USD Million)
  • 5.5. Magnetic Tracer
    • 5.5.1. Global Breast Lesion Localization Methods Market, by Magnetic Tracer, by Region, 2020-2034 (USD Million)
  • 5.6. Others
    • 5.6.1. Global Breast Lesion Localization Methods Market, by Others, by Region, 2020-2034 (USD Million)

6. Global Breast Lesion Localization Methods Market, by Geography

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Breast Lesion Localization Methods Market Assessment, by Geography, 2020-2034 (USD Million)
  • 6.3. Breast Lesion Localization Methods Market - North America
    • 6.3.1. North America: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.3.2. Breast Lesion Localization Methods Market - US
      • 6.3.2.1. US: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.3.3. Breast Lesion Localization Methods Market - Canada
      • 6.3.3.1. Canada: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • 6.4. Breast Lesion Localization Methods Market - Europe
    • 6.4.1. Europe: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.4.2. Breast Lesion Localization Methods Market - UK
      • 6.4.2.1. UK: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.4.3. Breast Lesion Localization Methods Market - France
      • 6.4.3.1. France: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.4.4. Breast Lesion Localization Methods Market - Germany
      • 6.4.4.1. Germany: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.4.5. Breast Lesion Localization Methods Market - Italy
      • 6.4.5.1. Italy: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.4.6. Breast Lesion Localization Methods Market - Spain
      • 6.4.6.1. Spain: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.4.7. Breast Lesion Localization Methods Market - Netherlands
      • 6.4.7.1. Netherlands: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.4.8. Breast Lesion Localization Methods Market - Russia
      • 6.4.8.1. Russia: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.4.9. Breast Lesion Localization Methods Market - Rest of Europe
      • 6.4.9.1. Rest of Europe: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • 6.5. Breast Lesion Localization Methods Market - Asia Pacific
    • 6.5.1. Asia Pacific: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.5.2. Breast Lesion Localization Methods Market - China
      • 6.5.2.1. China: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.5.3. Breast Lesion Localization Methods Market - India
      • 6.5.3.1. India: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.5.4. Breast Lesion Localization Methods Market - Malaysia
      • 6.5.4.1. Malaysia: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.5.5. Breast Lesion Localization Methods Market - Japan
      • 6.5.5.1. Japan: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.5.6. Breast Lesion Localization Methods Market - Indonesia
      • 6.5.6.1. Indonesia: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.5.7. Breast Lesion Localization Methods Market - South Korea
      • 6.5.7.1. South Korea: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.5.8. Breast Lesion Localization Methods Market - Australia
      • 6.5.8.1. Australia: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.5.9. Breast Lesion Localization Methods Market - Rest of Asia Pacific
      • 6.5.9.1. Rest of Asia Pacific: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • 6.6. Breast Lesion Localization Methods Market - Middle East & Africa
    • 6.6.1. Middle East & Africa: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.6.2. Breast Lesion Localization Methods Market - Saudi Arabia
      • 6.6.2.1. Saudi Arabia: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.6.3. Breast Lesion Localization Methods Market - UAE
      • 6.6.3.1. UAE: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.6.4. Breast Lesion Localization Methods Market - Israel
      • 6.6.4.1. Israel: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.6.5. Breast Lesion Localization Methods Market - South Africa
      • 6.6.5.1. South Africa: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.6.6. Breast Lesion Localization Methods Market - Rest of Middle East & Africa
      • 6.6.6.1. Rest of Middle East & Africa: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • 6.7. Breast Lesion Localization Methods Market - Latin America
    • 6.7.1. Latin America: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.7.2. Breast Lesion Localization Methods Market - Mexico
      • 6.7.2.1. Mexico: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.7.3. Breast Lesion Localization Methods Market - Brazil
      • 6.7.3.1. Brazil: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.7.4. Breast Lesion Localization Methods Market - Argentina
      • 6.7.4.1. Argentina: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.7.5. Breast Lesion Localization Methods Market - Rest of Latin America
      • 6.7.5.1. Rest of Latin America: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)

7. Competitive Landscape

  • 7.1. Expansion and Acquisition Analysis
    • 7.1.1. Expansion
    • 7.1.2. Acquisitions
  • 7.2. Partnerships/Collaborations/Agreements/Exhibitions

8. Company Profiles

  • 8.1. Hologic Inc.
    • 8.1.1. Company Overview
    • 8.1.2. Financial Performance
    • 8.1.3. Product Benchmarking
    • 8.1.4. Recent Development
  • 8.2. C.R. Bard (acquired by BD)
    • 8.2.1. Company Overview
    • 8.2.2. Financial Performance
    • 8.2.3. Product Benchmarking
    • 8.2.4. Recent Development
  • 8.3. MiMedx Group Inc.
    • 8.3.1. Company Overview
    • 8.3.2. Financial Performance
    • 8.3.3. Product Benchmarking
    • 8.3.4. Recent Development
  • 8.4. Cook Medical
    • 8.4.1. Company Overview
    • 8.4.2. Financial Performance
    • 8.4.3. Product Benchmarking
    • 8.4.4. Recent Development
  • 8.5. Endomag
    • 8.5.1. Company Overview
    • 8.5.2. Financial Performance
    • 8.5.3. Product Benchmarking
    • 8.5.4. Recent Development
  • 8.6. IZI Medical Products
    • 8.6.1. Company Overview
    • 8.6.2. Financial Performance
    • 8.6.3. Product Benchmarking
    • 8.6.4. Recent Development
  • 8.7. Thermo Fisher Scientific
    • 8.7.1. Company Overview
    • 8.7.2. Financial Performance
    • 8.7.3. Product Benchmarking
    • 8.7.4. Recent Development
  • 8.8. GE Healthcare
    • 8.8.1. Company Overview
    • 8.8.2. Financial Performance
    • 8.8.3. Product Benchmarking
    • 8.8.4. Recent Development
  • 8.9. Magee-Womens Hospital
    • 8.9.1. Company Overview
    • 8.9.2. Financial Performance
    • 8.9.3. Product Benchmarking
    • 8.9.4. Recent Development
  • 8.10. Siemens Healthineers
    • 8.10.1. Company Overview
    • 8.10.2. Financial Performance
    • 8.10.3. Product Benchmarking
    • 8.10.4. Recent Development
  • 8.11. Medtronic
    • 8.11.1. Company Overview
    • 8.11.2. Financial Performance
    • 8.11.3. Product Benchmarking
    • 8.11.4. Recent Development
  • 8.12. Philips Healthcare
    • 8.12.1. Company Overview
    • 8.12.2. Financial Performance
    • 8.12.3. Product Benchmarking
    • 8.12.4. Recent Development
  • 8.13. Fujifilm Corporation
    • 8.13.1. Company Overview
    • 8.13.2. Financial Performance
    • 8.13.3. Product Benchmarking
    • 8.13.4. Recent Development
  • 8.14. Johnson & Johnson
    • 8.14.1. Company Overview
    • 8.14.2. Financial Performance
    • 8.14.3. Product Benchmarking
    • 8.14.4. Recent Development
  • 8.15. Canon Medical Systems
    • 8.15.1. Company Overview
    • 8.15.2. Financial Performance
    • 8.15.3. Product Benchmarking
    • 8.15.4. Recent Development
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제